Fed. Circ. Panel Backs Invalidation Of OxyContin Patent
By Theresa Schliep · June 8, 2026, 7:17 PM EDT
The Federal Circuit on Monday upheld a Delaware federal court's decision that deemed invalid a Purdue Pharma patent covering an abuse-deterrent version of the opioid OxyContin, rebuffing the company's arguments that...
To view the full article, register now.